Head and neck nonmelanoma skin cancers: surgical management and debated issues.
Journal
Current opinion in otolaryngology & head and neck surgery
ISSN: 1531-6998
Titre abrégé: Curr Opin Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 9417024
Informations de publication
Date de publication:
04 Jan 2024
04 Jan 2024
Historique:
medline:
9
1
2024
pubmed:
9
1
2024
entrez:
9
1
2024
Statut:
aheadofprint
Résumé
This review critically assesses the current literature and guidelines, aiming to clarify some of the most important factors that impact surgical strategies of head and neck nonmelanoma skin cancers (NMSCs), focusing on squamous, basal, and Merkel cell carcinomas. Recent developments underscore the complexity of treatment for NMSC, particularly in the head and neck region. There is a lack of high-level evidence for the management of these tumors, especially in advanced stages. The need to tailor the extent of surgical margins and parotid/neck management to different histotypes, considering the varying risk factors for recurrence, is beginning to emerge in the literature. Moreover, the role of immunotherapy and targeted therapies for locally advanced disease, alongside traditional treatment options, is progressively growing. NMSCs represent a heterogeneous group of malignancies with varying treatment complexities and prognoses. Management of NMSC is evolving towards an increasingly personalized strategy within a multidisciplinary therapeutic framework.
Identifiants
pubmed: 38193646
doi: 10.1097/MOO.0000000000000960
pii: 00020840-990000000-00112
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Porceddu SV, Veness MJ, Guminski A. Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: current concepts, advances, and controversies. J Clin Oncol 2015; 33:3338–3345.
Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29:621–631.
Bichakjian C, Armstronget A, Baum C, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78:540–559.
Coggshall K, Tello TL, North JP, Yu SS. Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging. J Am Acad Dermatol 2018; 78:433–442.
Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Eur J Cancer 2020; 128:83–102.
Nahhas AF, Scarbrough CA, Trotter S. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol 2017; 10:37–46.
Godoy A, Ishii M, Dey J, et al. Facial lesions negatively impact affect display. Otolaryngol Head Neck Surg 2013; 149:377–383.
Bouhassira J, Bosc R, Greta L, et al. Factors associated with postoperative complications in elderly patients with skin cancer: a retrospective study of 241 patients. J Geriatr Oncol 2016; 7:10–14.
Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med 2018; 79:363–374.
Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. Epidemiology, diagnostics and prevention. Eur J Cancer 2020; 128:60–82.
Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023. Eur J Cancer 2023; 193:113251.
Schmults CD, Blitzblau R, Aasi SZ, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Squamous Cell Skin Cancer V.1.2024. © National Comprehensive Cancer Network, Inc. 2024. All right‘s reserved. To view the most recent and complete version of the guideline, go online to NCCN.org, 2023. [Accessed 9 November 2023].
Keohane SG, Botting J, Budny PG, et al. British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol 2021; 184:401–414.
Amin MB, Edge E, Greene F, et al. AJCC Cancer StagingManual (8th edition). New York. Springer International Publishing: American Joint Commission on Cancer; 2017.
Thompson AK, Kelley BF, Prokop LJ, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016; 152:419–428.
Cañueto J, Martín-Vallejo J, Cardeñoso-Álvarez E, et al. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma. Clin Exp Dermatol 2018; 43:876–882.
Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2 Treatment-Update 2023. Eur J Cancer 2023; 193:113252.
David AP, Miller MQ, Park SS, Christophel JJ. Comparison of outcomes of early vs delayed graft reconstruction of Mohs micrographic surgery defects. JAMA Facial Plast Surg 2019; 21:89–94.
Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27:241–248.
Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 2003; 112:57–63.
Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2003; 56:85–91.
Sapijaszko M, Zloty D, Bourcier M, et al. Nonmelanoma skin cancer in Canada chapter 5: management of squamous cell carcinoma. J Cutan Med Surg 2015; 19:249–259.
Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 51:1989–2007.
Newlands C, Currie R, Memon A, et al. Nonmelanoma skin cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130:S125–S132.
Ziegler A, Walker R, Varvares M. Oncologic outcomes of invasive squamous cell carcinoma of the scalp requiring resection of cranial bone. J Neurol Surg A Cent Eur Neurosurg 2016; 77:308–311.
Kadakia S, Ducic Y, Marra D, et al. Cutaneous squamous cell carcinoma of the scalp in the immunocompromised patient: review of 53 cases. Oral Maxillofac Surg 2016; 20:171–175.
Leach GA, Pflibsen LR, Mathew DP, et al. The role of resection of the outer table of the cranium in locally invasive primary squamous cell carcinoma of the scalp. J Craniofac Surg 2022; 33:1860–1864.
Johnson JT. Management of advanced cancers of the external nose. Oncology (Williston Park) 1993; 7:73–80.
Chipp E, Prinsloo D, Rayatt S. Rhinectomy for the management of nasal malignancies. J Laryngol Otol 2011; 125:1033–1037.
Teichgraeber JF, Goepfert H. Rhinectomy: timing and reconstruction. Otolaryngol Head Neck Surg 1990; 102:362–369.
Tyers AG. Orbital exenteration for invasive skin tumours. Eye 2006; 20:1165–1170.
Howard GR, Nerad JA, Carter KD, Whitaker DC. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol 1992; 113:123–133.
Tong JY, Huilgol SC, James C, et al. Perineural invasion and perineural spread in periocular squamous cell carcinoma. Eye (Basingstoke) 2023; 37:875–884.
Gerring RC, Ott CT, Curry JM, et al. Orbital exenteration for advanced periorbital nonmelanoma skin cancer: prognostic factors and survival. Eye (Basingstoke) 2017; 31:379–388.
Ali MJ, Pujari A, Dave TV, et al. Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India. Int Ophthalmol 2016; 36:253–258.
Venables ZC, Autier P, Nijsten T, et al. Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England. JAMA Dermatol 2019; 155:298–306.
Wilkie MD, Lancaster J, Roland NJ, Jones TM. Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: controversies and contemporary perspectives. Oral Oncol 2021; 120:105432.
Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976–990.
Sahovaler A, Krishnan R, Yeh D, et al. Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional lymph node metastasis: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2019; 145:352–360.
Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2012; 82:230–233.
Obermeier K, Tröltzsch M, Ehrenfeld M, Smolka W. Risk factors for lymph node metastases of facial cutaneous squamous cell carcinoma. J Craniomaxillofac Surg 2017; 45:1138–1142.
Brougham ND, Dennett ER, Cameron R, Tan. ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106:811–815.
R: Clark R, Soutar DS, Hunter KD. A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology 2010; 57:138–146.
Gonzalez-Guerrero M, Martínez-Camblor P, Vivanco B, et al. The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma. J Am Acad Dermatol 2017; 76:1139–1145.
Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head and Neck 2006; 28:785–791.
Grammatica A, Tomasoni M, Fior M, et al. Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases. Eur Arch Otorhinolaryngol 2022; 279:1573–1584.
Moore BA, Weber R, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115:1561–1567.
Osborne RF, Shaw T, Zandifar H, Kraus D. Elective parotidectomy in the management of advanced auricular malignancies. Laryngoscope 2008; 118:2139–2145.
Kadakia S, Saman M, Gordin E, et al. The role of parotidectomy in the treatment of auricular squamous cell carcinoma. Otolaryngol Head Neck Surg 2005; 152:1048–1052.
Wong WK, Morton RP. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014; 271:3011–3019.
Cannon RB, Dundar Y, Thomas A, et al. Elective neck dissection for head and neck cutaneous squamous cell carcinoma with skull base invasion. Otolaryngol Head Neck Surg 2017; 156:671–676.
Smith JA, Virk S, Palme C, et al. Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2018; 88:E273–E277.
Peris K, Fargnoli M, Kaufmann R, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma: update 2023. Eur J Cancer 2023; 192:113254.
Peris K, Fargnoli M, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118:10–34.
Quazi SJ, Aslam N, Saleem H, et al. Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020; 12:e9211.
Schmults CD, Blitzblau R, Aasi, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell Skin Cancer V.2.2024. © National Comprehensive Cancer Network, Inc. 2024. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org., 2023. [Accessed 14 September 2023].
Nasr I, McGrath E, Harwood C, et al. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021∗. Br J Dermatol 2021; 185:899–920.
Masud D, Moustaki M, Staruch R, Dheansa B. Basal cell carcinomata: risk factors for incomplete excision and results of re-excision,. J Plastic Reconstruct Aesthet Surg 2016; 69:652–656.
Swann MH, Yoon J. Merkel cell carcinoma. Semin Oncol 2007; 34:51–56.
Schmults CD, Blitzblau R, Aasi SZ, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Merkel Cell Carcinoma V.1.2024. © National Comprehensive Cancer Network, Inc. 2024. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org., 2023. [Accessed 22 November 2023].
Gauci ML, Aristei C, Becker J, et al. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer 2022; 171:203–231.
Morand GB, Madana J, Da Silva SD, et al. Merkel cell carcinoma of the head and neck: poorer prognosis than nonhead and neck sites. J Laryngol Otol 2016; 130:393–397.
Yesul Kim. Adjuvant radiotherapy may not significantly change outcomes in high-risk cutaneous squamous cell carcinomas with clear surgical margins: a systematic review and meta-analysis. J Am Acad Dermatol 2022; 86:1246–1257.
Zhang J, Wang Y, Wijaya WA, et al. Efficacy and prognostic factors of adjuvant radiotherapy for cutaneous squamous cell carcinoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2021; 35:1777–1787.
Jackson JE, Dickie G, Wiltshire K, et al. Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck 2009; 31:604–610.
Drucker AM, Adam G, Rofeberg V, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med 2018; 169:456–466.
Takagishi SR, Marx T, Lewis C, et al. Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck. Adv Radiat Oncol 2016; 1:244–251.
Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012; 23:1074–1080.
Brandt MG, Moore CC. Nonmelanoma skin cancer. Facial Plast Surg Clin N Am 2019; 27:1–13.
Russo GM, Russo A, Urraro F, et al. Management of non-melanoma skin cancer: radiologists challenging and risk assessment. Diagnostics (Basel) 2023; 13:793.
Lorini L, Alberti A, Bossi P. Advanced cutaneous squamous cell carcinoma management in immunotherapy era: achievements and new challenges. Dermatol Pract Concept 2023; 13:e2023251.